Pharmaceuticals in Singapore

May 2020 | 52 pages | ID: P5B6478CDADEN
MarketLine

Abstracts

Pharmaceuticals in Singapore

SUMMARY

Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY HIGHLIGHTS

• The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
• The Singaporean pharmaceuticals market had total revenues of $940.6m in 2019, representing a compound annual growth rate (CAGR) of 2% between 2015 and 2019.
• The Singaporean healthcare is the best in the world in terms of both efficiency and health outcome results. Singapore has a record of providing a world-class business environment and skilled talent pool to companies.
• The Singapore government has invested aggressively in its biomedical industry over the last few years.

SCOPE

• Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Singapore
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore
• Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts

REASONS TO BUY

• What was the size of the Singapore pharmaceuticals market by value in 2019?
• What will be the size of the Singapore pharmaceuticals market in 2024?
• What factors are affecting the strength of competition in the Singapore pharmaceuticals market?
• How has the market performed over the last five years?
• Who are the top competitiors in Singapore's pharmaceuticals market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What trends have impacted the market?
7.6. Are there any threats towards leading players?

8 COMPANY PROFILES

8.1. Novartis AG
8.2. Pfizer Inc.
8.3. Astellas Pharma Inc.
8.4. GlaxoSmithKline Plc

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Singapore pharmaceuticals market value: $ billion, 2015-19
Table 2: Singapore pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Singapore pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Singapore pharmaceuticals market share: % share, by value, 2019
Table 5: Novartis AG: key facts
Table 6: Novartis AG: Annual Financial Ratios
Table 7: Novartis AG: Annual Financial Ratios (Continued)
Table 8: Novartis AG: Key Employees
Table 9: Novartis AG: Key Employees Continued
Table 10: Pfizer Inc.: key facts
Table 11: Pfizer Inc.: Annual Financial Ratios
Table 12: Pfizer Inc.: Key Employees
Table 13: Pfizer Inc.: Key Employees Continued
Table 14: Astellas Pharma Inc.: key facts
Table 15: Astellas Pharma Inc.: Annual Financial Ratios
Table 16: Astellas Pharma Inc.: Key Employees
Table 17: Astellas Pharma Inc.: Key Employees Continued
Table 18: GlaxoSmithKline Plc: key facts
Table 19: GlaxoSmithKline Plc: Annual Financial Ratios
Table 20: GlaxoSmithKline Plc: Annual Financial Ratios (Continued)
Table 21: GlaxoSmithKline Plc: Key Employees
Table 22: GlaxoSmithKline Plc: Key Employees Continued
Table 23: Singapore size of population (million), 2015-19
Table 24: Singapore gdp (constant 2005 prices, $ billion), 2015-19
Table 25: Singapore gdp (current prices, $ billion), 2015-19
Table 26: Singapore inflation, 2015-19
Table 27: Singapore consumer price index (absolute), 2015-19
Table 28: Singapore exchange rate, 2015-19

List Of Figures

LIST OF FIGURES

Figure 1: Singapore pharmaceuticals market value: $ billion, 2015-19
Figure 2: Singapore pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Singapore pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Singapore, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Singapore, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Singapore, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2019
Figure 10: Singapore pharmaceuticals market share: % share, by value, 2019